CDKN1A and neoplasm: Interestingly, patients with p21/P-S6-double-positive tumours presented lower rates of recurrence (including local recurrences, regional recurrences and distant metastasis) and lower incidence of distant metastases (Fig. 6e and Supplementary Tables 6,7).